17-May-2024 | Facts and Factors
As per the report published by Facts & Factors, the global Digital Pathology market was valued at approximately USD 1,340 Million in 2023 and is expected to generate revenue of around USD 3,210 Million by end of 2032, growing at a CAGR of around 10.19% between 2024 and 2032.
Digital pathology is image-based data from digitized specimen slides. It is done by using a virtual microscope. During disease diagnosis, digitization of pathology is performed at hospitals, diagnostic centers. It offers high-resolution sample scanning, analysis of computer images, and online storage of digital slides which enables pathologists to examine slides without forensic evidence.
Rising Prevalence of Chronic Conditions
The increasing prevalence of chronic conditions is projected to increase clinical urgency to take digital pathology in order to improve the current poor diagnostic imaging measures and to reduce the high cost of conventional diagnostics. As per the survey, the total number of chronic respiratory disease cases increased by 39.5% between 1990 to 2017. At COVID-19, a Digital Pathology Enforcement Policy for Pathologists, clinical laboratories, healthcare centers, and drug management staff was issued by the US FDA's Center for Devices and Radiological Health. The document sets out a policy framework for increasing the availability of digital devices for remote pathology in such a critical situation. Supportive regulations are expected to have a positive impact on the market in the coming years.
North America is projected To Dominate the Global Digital Pathology Market
North America accounted for the major market share among the others, and it has been expected to maintain this trend in the near future, owing to the huge adoption of digital pathology systems. Moreover, the easy accessibility of digital pathology products and the growing need for digital pathology over the traditional methods fuel the market growth.
Asia-Pacific is expected to record the highest rate of growth over the next few years due to a rise in awareness of digital pathology systems. The presence of a large patient base with chronic & infectious diseases and an increase in expenditure on healthcare infrastructure will support the market growth during the forecast timeline. Moreover, the ever-changing life science sector is predicted to offer lucrative market expansion opportunities in developing economies such as China, India, and Malaysia.
Report Scope
Report Attribute |
Details |
Market Size in 2023 |
USD 1,340 Million |
Projected Market Size in 2032 |
USD 3,210 Million |
CAGR Growth Rate |
10.19% CAGR |
Base Year |
2023 |
Forecast Years |
2024-2032 |
Key Market Players |
3DHISTECH, Akoya Biosciences Inc., Apollo Enterprise Imaging, Bionovation Biotech Inc., ContextVision AB, Danaher Corporation, F. Hoffmann-La Roche Ltd., Fujifilm Holdings Corporation, Glencoe Software Inc., Hamamatsu Photonics K.K., Hologic Inc., Huron Technologies International Inc., Indica Labs Inc., Inspirata Inc., Koninklijke Philips N.V., Leica Biosystems Nussloch GmbH (Danaher), Mikroscan Technologies Inc., Morphle Labs Inc, Motic Digital Pathology, Olympus Corp., OptraSCAN, Paige AI Inc., PathAI, Proscia Inc., Sectra AB, SigTuple Technologies Private Limited, Visiopharm A/S, and Others. |
Key Segment |
By Product Type, By Application, By End User, and By Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Top Market Players
Major players in the market are 3DHISTECH, Akoya Biosciences, Inc., Apollo Enterprise Imaging, Bionovation Biotech, Inc., ContextVision AB, Danaher Corporation, F. Hoffmann-La Roche Ltd., Fujifilm Holdings Corporation, Glencoe Software, Inc., Hamamatsu Photonics K.K., Hologic, Inc., Huron Technologies International Inc., Indica Labs Inc., Inspirata, Inc., Koninklijke Philips N.V., Leica Biosystems Nussloch GmbH (Danaher), Mikroscan Technologies, Inc., Morphle Labs, Inc, Motic Digital Pathology, Olympus Corp., OptraSCAN, Paige AI, Inc., PathAI, Proscia Inc., Sectra AB, SigTuple Technologies Private Limited, Visiopharm A/S, and others.
Browse the full“Digital Pathology Market Size, Share, Growth Analysis Report By Product Type (Hardware, Software, and Services), By Application (Disease Diagnosis, Drug Discovery & Development, and Research & Education), By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Academic & Research Institutions), And By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2024 – 2032” report at https://www.fnfresearch.com/digital-pathology-market-report
The Global Digital Pathology Market is segmented as follows:
By Product Type
- Hardware
- Slide Scanners
- Image Management Systems (IMS)
- Digital Analysis Workstations
- Software
- Image Analysis (IA) Software
- Reporting and Collaboration Tools
- Services
- Implementation and Training
- Data Management and Security
- Remote Interpretation
By Application
- Disease Diagnosis
- Oncology
- Neuropathology
- Dermatopathology
- Drug Discovery & Development
- Research & Education
By End User
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutions
By Region:
- North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of the Middle East & Africa
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1 (347) 690-0211
Email: [email protected]
Web: https://www.fnfresearch.com
